PAX6 Genotypic and Retinal Phenotypic Characterization in Congenital Aniridia.
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
11 05 2020
11 05 2020
Historique:
entrez:
13
5
2020
pubmed:
13
5
2020
medline:
22
9
2020
Statut:
ppublish
Résumé
To investigate the association between PAX6 genotype and macular morphology in congenital aniridia. The study included 37 participants (15 males) with congenital aniridia (aged 10-72 years) and 58 age-matched normal controls (18 males). DNA was isolated from saliva samples. PAX6 exons, intron/exon junctions, and known regulatory regions were amplified in PCR and sequenced. Multiplex ligation-dependent probe amplification (MLPA) was performed to detect larger deletions or duplications in PAX6 or known cis-regulatory regions. Spectral-domain optical coherence tomography images were acquired and segmented semiautomatically. Mean thicknesses were calculated for inner and outer retinal layers within the macula along nasal and temporal meridians. Mutations in PAX6 or regulatory regions were found in 97% of the participants with aniridia. Foveal hypoplasia was observed in all who had a mutation within the PAX6 gene. Aniridic eyes had thinner outer retinal layers than controls, but with large between-individual variation (mean ± SD, 156.3 ± 32.3 µm vs 210.8 ± 12.3 µm, P < 0.001). Parafoveal and perifoveal inner and outer retinal layers were thinner in aniridia. Participants with mutations in noncoding PAX6 regions had thicker foveal outer retinal layers than those with mutations in the PAX6 coding regions (P = 0.04) and showed signs of postnatal development and maturation. Mutations outside the PAX6 gene were associated with the mildest retinal phenotypes. PAX6 mutations are associated with significant thinning of macular inner and outer retinal layers, consistent with misdirected retinal development resulting in abnormal foveal formation and reduced number of neurons in the macula, with mutations in PAX6 coding regions giving the worst outcome.
Identifiants
pubmed: 32396632
pii: 2766104
doi: 10.1167/iovs.61.5.14
pmc: PMC7405610
doi:
Substances chimiques
PAX6 Transcription Factor
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
14Subventions
Organisme : NEI NIH HHS
ID : P30 EY001730
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY028118
Pays : United States
Références
Prog Retin Eye Res. 2012 Sep;31(5):351-76
pubmed: 22561546
Can J Ophthalmol. 2017 Dec;52(6):570-577
pubmed: 29217025
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13755-9
pubmed: 11087823
Hum Mol Genet. 2001 Sep 15;10(19):2049-59
pubmed: 11590122
Mol Vis. 2018 Mar 28;24:261-273
pubmed: 29618921
Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3257-8
pubmed: 15326148
Dev Biol. 2017 Dec 1;432(1):140-150
pubmed: 28993200
Am J Ophthalmol. 2012 Nov;154(5):779-789.e2
pubmed: 22898189
Development. 2008 Dec;135(24):4037-4047
pubmed: 19004853
Am J Hum Genet. 2013 Dec 5;93(6):1126-34
pubmed: 24290376
Front Genet. 2018 Oct 17;9:479
pubmed: 30386378
Vis Neurosci. 2005 Mar-Apr;22(2):171-85
pubmed: 15935110
Ophthalmology. 2011 Aug;118(8):1653-60
pubmed: 21529956
PLoS Genet. 2014 May 29;10(5):e1004360
pubmed: 24875170
Cell. 2001 Apr 6;105(1):43-55
pubmed: 11301001
Genome Res. 2007 May;17(5):545-55
pubmed: 17387144
Hum Genet. 2001 Jul;109(1):11-8
pubmed: 11479730
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4537-45
pubmed: 26200492
Hum Genet. 2018 Oct;137(10):831-846
pubmed: 30291432
Arch Ophthalmol. 1993 Jun;111(6):831-6
pubmed: 8512486
Eur J Hum Genet. 1999 Apr;7(3):274-86
pubmed: 10234503
Neural Dev. 2009 Aug 17;4:32
pubmed: 19686589
Hum Mutat. 2016 Jun;37(6):564-9
pubmed: 26931183
Opt Express. 2009 Dec 21;17(26):23719-28
pubmed: 20052083
Ophthalmol Retina. 2019 Jun;3(6):523-534
pubmed: 31174676
J Dev Biol. 2019 Aug 14;7(3):
pubmed: 31416264
Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4120-4128
pubmed: 31574536
Am J Hum Genet. 1960 Dec;12(4 Pt 1):389-415
pubmed: 17948455
Cell. 1991 Dec 20;67(6):1059-74
pubmed: 1684738
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Retina. 2015 Aug;35(8):1511-20
pubmed: 25829348
Hum Mol Genet. 1999;8(10):1893-900
pubmed: 10469842
PLoS One. 2016 Apr 28;11(4):e0153757
pubmed: 27124303
Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4298-306
pubmed: 20357200
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Heliyon. 2019 Feb 28;5(2):e01271
pubmed: 30891515
Surv Ophthalmol. 2018 Jan - Feb;63(1):105-113
pubmed: 28923585
Br J Ophthalmol. 2019 Jan;103(1):119-124
pubmed: 29519880
Ophthalmology. 2020 Feb;127(2):273-275
pubmed: 31708273
Acta Ophthalmol. 2008 Nov;86(7):727-9
pubmed: 18494745
Am J Hum Genet. 2005 Jan;76(1):8-32
pubmed: 15549674
Development. 2014 Mar;141(6):1292-302
pubmed: 24523460
Hum Genome Var. 2016 Feb 11;3:15052
pubmed: 27081561
Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2581-90
pubmed: 19218613
Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):2142-2152
pubmed: 29801149
J Cell Biol. 1989 Feb;108(2):229-41
pubmed: 2645293
Prog Retin Eye Res. 2013 Jul;35:63-81
pubmed: 23500068
Eur J Ophthalmol. 2020 Jan;30(1):58-65
pubmed: 30556423
Arch Ophthalmol. 1965 Mar;73:338-41
pubmed: 14246186
Neurosci Biobehav Rev. 2014 Oct;46 Pt 2:175-86
pubmed: 24239855
BMC Genet. 2005 May 26;6:27
pubmed: 15918896